Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease

NCT03462277 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT03462277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03462277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation and Hydroxymethylation Levels in Patients With Coronary Heart Disease
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
October 1, 2018
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease